Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Eclinicalmedicine
|
June 11, 2025
Safety and feasibility of anlotinib in children with high risk, recurrent or refractory sarcomas: an open-label, single-centre, single-arm, phase Ia/Ib trial
Suying Lu, Yi Que, Dongyang Liu, et al.
International Journal of Cancer
|
June 26, 2026
Targeted Therapy and Oral Chemotherapy as Maintenance Treatment in Pediatric Very-High-Risk and High-Risk Rhabdomyosarcoma: A Retrospective Study of Efficacy and Safety
Lei Mao, Yumiao Mai, Suying Lu, et al.
BMC Psychiatry
|
January 11, 2021
Systematic content analysis of patient evaluations of START NOW psychotherapy reveals practical strategies for improving the treatment of opioid use disorder
Albert Yi-Que Truong, Brian Fabian Saway, Malek H Bouzaher, et al.
Frontiers in Immunology
|
June 26, 2023
Efficacy and safety of programmed cell death receptor 1 inhibition-based regimens in patients with pediatric malignancies: the real-world study in China
Ye Hong, Mengjia Song, Yingxia Lan, et al.
Oncoimmunology
|
May 30, 2026
Umbilical cord blood natural killer cells improve anti-GD2 antibody efficacy in neuroblastoma: from mouse to human
Mengjia Song, Yingxia Lan, Xiya Tan, et al.
Frontiers in Pharmacology
|
August 1, 2024
Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study
Junting Huang, Jia Zhu, Lian Jiang, et al.
Cancer Cell
|
March 16, 2017
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma
QiWen Fan, Ozlem Aksoy, Robyn A Wong, et al.
Cell Reports. Medicine
|
August 16, 2023
Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma
Qiuzhong Pan, Desheng Weng, Jiayong Liu, et al.
Journal for Immunotherapy of Cancer
|
February 27, 2021
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma
Yi Que, Xiao-Long Zhang, Ze-Xian Liu, et al.
JCO Precision Oncology
|
January 14, 2026
Precision Medicine Program in Chinese Pediatric Patients With Sarcoma
Suying Lu, Yu Zhang, Weiling Zhang, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Eclinicalmedicine
|
June 11, 2025
Safety and feasibility of anlotinib in children with high risk, recurrent or refractory sarcomas: an open-label, single-centre, single-arm, phase Ia/Ib trial
Suying Lu, Yi Que, Dongyang Liu, et al.
International Journal of Cancer
|
June 26, 2026
Targeted Therapy and Oral Chemotherapy as Maintenance Treatment in Pediatric Very-High-Risk and High-Risk Rhabdomyosarcoma: A Retrospective Study of Efficacy and Safety
Lei Mao, Yumiao Mai, Suying Lu, et al.
BMC Psychiatry
|
January 11, 2021
Systematic content analysis of patient evaluations of START NOW psychotherapy reveals practical strategies for improving the treatment of opioid use disorder
Albert Yi-Que Truong, Brian Fabian Saway, Malek H Bouzaher, et al.
Frontiers in Immunology
|
June 26, 2023
Efficacy and safety of programmed cell death receptor 1 inhibition-based regimens in patients with pediatric malignancies: the real-world study in China
Ye Hong, Mengjia Song, Yingxia Lan, et al.
Oncoimmunology
|
May 30, 2026
Umbilical cord blood natural killer cells improve anti-GD2 antibody efficacy in neuroblastoma: from mouse to human
Mengjia Song, Yingxia Lan, Xiya Tan, et al.
Frontiers in Pharmacology
|
August 1, 2024
Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study
Junting Huang, Jia Zhu, Lian Jiang, et al.
Cancer Cell
|
March 16, 2017
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma
QiWen Fan, Ozlem Aksoy, Robyn A Wong, et al.
Cell Reports. Medicine
|
August 16, 2023
Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma
Qiuzhong Pan, Desheng Weng, Jiayong Liu, et al.
Journal for Immunotherapy of Cancer
|
February 27, 2021
Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma
Yi Que, Xiao-Long Zhang, Ze-Xian Liu, et al.
JCO Precision Oncology
|
January 14, 2026
Precision Medicine Program in Chinese Pediatric Patients With Sarcoma
Suying Lu, Yu Zhang, Weiling Zhang, et al.
Page
of 6